Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > LATAM'S moat

<< Previous

Bullboard Posts

Next >>

Comment by Snowballgrowthon Oct 20, 2020 6:01am

83 Views

Post# 31746734

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:LATAM'S moat

Benedict16th wrote: Ok..ok...than forget the ticker price but look at your current GUD account balance and compare it to last Year. Hart to fa rt against numbers my friend. I know where my is at. Your not much different

If the business behind the ticker have much better earning power we are in a better position. I think this is the case. That said even if a lower stock price is better for long term shareholders (ref buybacks), I can easy understand it can be temporary uncomfortable for some including you. I don't judge you for this. Not everyone have the same situation.

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida